Everybody responds differently. Lilly's Triple Agonist, Retatrutide, Successful in Two Additional Phase 3 Obesity Trials, Delivering Significant Improvements in Weight and A1C
Safety & side effects Common side effects The most common side effects are gastrointestinal, nausea, diarrhea, vomiting, and constipation, usually mild to moderate and most likely while your dose is being increased
Insulin signaling pathway Insulin signaling in the brain is vital for the brain activity, and insulin resistance is one of key reasons of AD (213)
If you are planning pregnancy, discuss this with your doctor as GLP-1 medications are not recommended during pregnancy or breastfeeding
Building Your GLP-1 Relief Kit Managing your health journey doesn't have to be miserable
High-quality studies ensure treatment decisions are evidence-based, with the SURPASS program offering the most comprehensive evaluation across multiple doses and populations